Small molecule inhibitors of HCV replication from Pomegranate

Hepatitis C virus (HCV) is the causative agent of end-stage liver disease. Recent advances in the last decade in anti HCV treatment strategies have dramatically increased the viral clearance rate. However, several limitations are still associated, which warrant a great need of novel, safe and select...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, B. Uma, Mullick, Ranajoy, Kumar, Anuj, Sudha, Govindarajan, Srinivasan, Narayanaswamy, Das, Saumitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067622/
https://www.ncbi.nlm.nih.gov/pubmed/24958333
http://dx.doi.org/10.1038/srep05411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067622/
https://www.ncbi.nlm.nih.gov/pubmed/24958333
http://dx.doi.org/10.1038/srep05411

Ejemplares similares